DISCOVER

Lyonbiopole's governance




Management team


The Board of Directors and the Technical Group are supported by a management team consisting of 13 persons.


Missions

> Initiates and supports the setup of multi-partner R&D projects and monitors them throughout deployment

> Brings in human and financial resources for cluster projects

> Assists the economic development of SMBs

> Implements the communication plan and organizes special events between cluster members

> Organizes information exchange between firms, technical institutes and SMBs

> Promotes the cluster and manages international development of its R&D projects and members

> Handles day-to-day management of the association as well as relations with funding organizations.

 

 

Composition

A 13-person team composed of staff from the general Management, scientific Management, economic & international affairs Division, communication Department and the Infectious Diseases Center Management.

 

LYONBIOPOLE

Philippe Archinard, President
Yves Laurent, General Manager


Scientific direction
Bernard Mandrand, Scientific Director
Claudia Chagneau, Projects Manager
Estelle Vincent, Projects Management Assistant
Pauline Cottin, Sepsis programm Coordinator
For further information about R&D projects: projets@lyonbiopole.com

Economic & International Affairs and Communication Direction
Isabelle Scarabin, Economic & International Affairs Director
Kevin Romani, International Project Manager
Emilie Roméo, Project Manager
Périne Michon, Communication Assistant
For further information: info@lyonbiopole.com


Administratif and Comptable Service
Audrey Guilbert, Administrative and Accounting
Bérangère Maire, an assistant in sandwich course


INFECTIOUS DISEASES CENTER

François Martin
, Director
Ludovic Dolt, Technician of industrial maintenance
Marie-Claire Gallet, Support logistics and technical laboratory


The members...



They speak about...


« The Pharma industry had mixed performance with regard to products approvals and pipeline development. However, innovative drugs are delivered by Biotech companies, focused on technologic know-how platform development and advanced pipeline candidates with both scientific and commercial potential. In France, the Rhône-Alpes region offers and develops a strong Biotech cluster dedicated on drug discovery, in vivo animal models, bio production and early safety prediction, all critical aspects of therapeutic antibodies development. »


Claudine Vermot-Desroches

iDD Biotech - R&D Director

DOCUMENTATION | CONTACT | SEARCH